UK-based Helma Health Technology acquired prenatal and prenatal health AI company Pirigon earlier this week for $ 58 million.
Linn Founded in 2000, Perigen makes clinics-based delivery products that provide more patient information to clinics based on software and analysis. With its early warning system and clinical decision support tool, you can use artificial intelligence to monitor patients in labor and find any problems that can be solved in time.
The device was designed to help clinicians interpret complex data. Central surveillance and patient counting as well as bedside monitoring.
According to the announcement, M&A will be given “additional reps” to build the technology in the United States and elsewhere.
“Over the past few years, we have seen a great deal of change in Perigen and the integration of the management team, investors and, above all, the needs of our clients and patients,” said Perigen CEO Matthew Sapper.
“Over the years, we have taken financial stability and product discipline into North America and soon to become part of Halma PLC. We are excited about what the future holds for our company.
Why it is important
The United States has one of the highest maternal and infant mortality rates in the world. Linn In 2018, infant mortality in the United States was 5.7 deaths per 1,000 live births. According to the CDC. This number is even higher for black children, with 10.8 births per 1,000 births. Native Americans and Native Hawaiian or Pacific Islanders are also affected.
Today, technologists are using digital health to help solve this problem.
The biggest trend
Perigen has already made some big deals. In 2018, the company signed an agreement The life of Quelcom, Allows you to sell the latest license and PeriWatch enabled. In the same year Popular Health He brought Perigen’s Perigach labor control and analysis software to the maternity ward.
But Perigen is not the only company focusing on maternity leave. Maternity Care Management Company Dorta In April 2020, it received $ 5.2 million in consecutive A funding.
There is also conspiracy prognosis. In January Sera Prognostics merged with Anthem And randomized controlled trials and health halls by examining the effectiveness of the PRETRM trial to reduce risk, improve newborn outcomes, and reduce overall health care costs.